Michele Wispelwey, MBA

18 years in practice

Founder & CEO · FemGevity Health

Founder and CEO with 18 years in women's health diagnostics at LabCorp, Quest, and Accurate Diagnostics

Michele Wispelwey, MBA portrait

About

Michele Wispelwey, MBA is FemGevity's founder and CEO. Before launching the company, she spent more than 18 years in women's health diagnostics through LabCorp, Quest Diagnostics, and Accurate Diagnostics, where she led women's health services across molecular diagnostics, genetics, and cytology. That career explains FemGevity's testing-led model: broad panels first, then specialist interpretation and care planning. Wispelwey co-founded FemGevity in 2022 with certified nurse-midwife Kristin Mallon, CNM, MS, RNC-OB and now leads strategy, operations, partnerships, and the company's femtech presence.

What to Know

Signature approach

Wispelwey's operating lens is diagnostics translated into care. Her lab-industry years showed how much molecular, genetic, and cytology testing could reveal for women in midlife, and how hard it was for that information to reach patients in an actionable form. At FemGevity, she builds around reference-lab partnerships, virtual access, and a clinician team responsible for turning data into treatment decisions.

What sets them apart

  • Lab-industry background. LabCorp, Quest Diagnostics, and Accurate Diagnostics gave her direct experience with the testing infrastructure FemGevity depends on.
  • Women's health program building. Her Accurate Diagnostics role focused on molecular diagnostics, genetics, and cytology for women's health.
  • Femtech network. Wispelwey appears across podcasts, panels, Adesso Health, New Pause Symposium, and FemTech Focus Summit settings.

Affiliations

Founder

Thought Leadership

Media Appearances

Other specialists at FemGevity Health

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.